Bepanthen® is a globally trusted brand that supports the management of atopic eczema and has over 75 years of expertise in medicated skincare and skin healing

Eczema also known as atopic eczema or atopic dermatitis affects about

20% of children
20% of
children
10% of adults
10% of
adults

and is associated with a high burden of morbidity and costs to individuals and health services.1

Overall, 10-year increases in lifetime prevalence:1


The overall prevalence of AD in the UAE was 16.7%.2

The overall prevalence of reported AD is 39.1%,
higher than the diagnosed AD.2

When only ISAAC criteria were considered.
Dubai

In Dubai and the Northern Emirates:2

  • Children aged 6–7 years reported 12.9%.
  • Children aged 13–14 years reported 14.6%.
    (n= 3436 school children)

From Dubai Real-World Database:2

The prevalence of mild-to-moderate AD in this population is 5.5%.

Healthy lamellar lipids

In healthy skin, lamellar lipids are layered in a tight configuration, preventing moisture from escaping.3,4

Flare lamellar lipids

During a flare, the skin’s lamellar lipids are shorter and broken, leaving gaps that allow water to escape and allergens, irritants and pathogens to penetrate.3,4

Lipid Lamellar Technology

Lipid Lamellar Technology features lipids such as free fatty acids and ceramides. These integrate and bind to lipids in damaged skin, filling in gaps and arranging themselves in the right order to restore the skin barrier.5

AD: atopic dermatitis; UAE: United Arab Emirates; ISAAC: international skin and anti ageing center.

References:
1.Langan, S. M., Mulick, A. R., Rutter, C. E., Silverwood, R. J., Asher, I., García‐Marcos, L., ... & Shah, J. (2023). Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study. Clinical & Experimental Allergy, 53(3), 337-352. 2.Mahmoud, O., Yosipovitch, G., & Attia, E. (2023). Burden of disease and unmet needs in the diagnosis and management of atopic dermatitis in the Arabic population of the Middle East. Journal of clinical medicine, 12(14), 4675.3.van Smeden J et al. Biochim Biophys Acta 2014;1841:295–313. 4.Danby SG and Cork MJ. J Clin Dermatol 2010;1:33–46. 5.Stettler H et al. KOM Dermatol News 2016;11:1–11.